Desyncra™ is a medical technology company for the treatment of brain-related conditions. Our award-winning Coordinated Reset (CR®) Neuromodulation technology was developed by Professor Peter Tass at the Jülich Research Centre, and can be used for the treatment of: tinnitus, Parkinson's disease, epilepsy, and migraine. Our T30 device for tinnitus has FDA approval and the CE mark and is currently available in the UK, Germany, Netherlands and Switzerland.
Company Details
- Founded
- -
- Address
- Bewlay House, 2 Swallow Place,united Kingdom
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.desyncra.com/
- HQ
- London
Desyncra Technologies Ltd. Questions
Desyncra Technologies Ltd.'s website is http://www.desyncra.com/
Desyncra Technologies Ltd.'s LinkedIn profile is https://uk.linkedin.com/company/desyncra-technologies-ltd-
Desyncra Technologies Ltd.'s industry is
Medical Equipment Manufacturing
Desyncra Technologies Ltd.'s top competitors are
Hr4p B.v.,
Dls Projects Bv,
Mobula-Igm,
Riumssen,
Wijnhuis Beaugrim,
Sahya,
Litechnica Ltd,
Fox Red Wealth Management Ltd,
Soundlink Co.,ltd.,
Paterskerk Weert.
Desyncra Technologies Ltd.'s categories are Medical Equipment Manufacturing
Desyncra Technologies Ltd.'s founding year is 2015
